Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I.

Saved in:
Bibliographic Details
Title: Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I.
Authors: Unger JM; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Qian L; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Redman MW; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Tavernier SS; Idaho State University, Pocatello, ID, USA., Minasian L; Division of Cancer Prevention, National Cancer Institute, Community Oncology and Prevention Trials Group, Rockville, MD, USA., Sigal EV; Friends of Cancer Research, Washington, DC, USA., Papadimitrakopoulou VA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pfizer Oncology, Inc, New York, NY, USA., Leblanc M; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Cleeland CS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dzingle SA; SWOG Data Operations Center, Cancer Research and Biostatistics, Seattle, WA, USA., Summers TJ; Cookeville Regional Medical Center, Southeast NCORP, Cookeville, TN, USA., Chao H; Veterans Affairs Connecticut Healthcare System, Yale University School of Medicine, Massachusetts Veterans Epidemiology Research and Information Center, New Haven, CT, USA., Madhusudhana S; University Health Truman Medical Center, University of Kansas Cancer Center-Midwest Cancer Alliance Rural MU National Cancer Institute Community Oncology Research Program, Kansas City, MO, USA., Villaruz L; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA., Crawford J; Duke Cancer Institute, Durham, NC, USA., Gray JE; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Kelly KL; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Gandara DR; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Bazhenova L; University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Herbst RS; Yale Cancer Center, New Haven, CT, USA., Gettinger SN; Yale Cancer Center, New Haven, CT, USA., Moinpour CM; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Apr 11; Vol. 115 (4), pp. 437-446.
Publication Type: Clinical Trial, Phase III; Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36625510
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Unger+JM%22">Unger JM</searchLink>; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Qian+L%22">Qian L</searchLink>; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Redman+MW%22">Redman MW</searchLink>; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Tavernier+SS%22">Tavernier SS</searchLink>; Idaho State University, Pocatello, ID, USA.<br /><searchLink fieldCode="AU" term="%22Minasian+L%22">Minasian L</searchLink>; Division of Cancer Prevention, National Cancer Institute, Community Oncology and Prevention Trials Group, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Sigal+EV%22">Sigal EV</searchLink>; Friends of Cancer Research, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Papadimitrakopoulou+VA%22">Papadimitrakopoulou VA</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pfizer Oncology, Inc, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Leblanc+M%22">Leblanc M</searchLink>; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Cleeland+CS%22">Cleeland CS</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Dzingle+SA%22">Dzingle SA</searchLink>; SWOG Data Operations Center, Cancer Research and Biostatistics, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Summers+TJ%22">Summers TJ</searchLink>; Cookeville Regional Medical Center, Southeast NCORP, Cookeville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Chao+H%22">Chao H</searchLink>; Veterans Affairs Connecticut Healthcare System, Yale University School of Medicine, Massachusetts Veterans Epidemiology Research and Information Center, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Madhusudhana+S%22">Madhusudhana S</searchLink>; University Health Truman Medical Center, University of Kansas Cancer Center-Midwest Cancer Alliance Rural MU National Cancer Institute Community Oncology Research Program, Kansas City, MO, USA.<br /><searchLink fieldCode="AU" term="%22Villaruz+L%22">Villaruz L</searchLink>; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Crawford+J%22">Crawford J</searchLink>; Duke Cancer Institute, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Gray+JE%22">Gray JE</searchLink>; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Kelly+KL%22">Kelly KL</searchLink>; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gandara+DR%22">Gandara DR</searchLink>; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bazhenova+L%22">Bazhenova L</searchLink>; University of California San Diego Moores Cancer Center, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Herbst+RS%22">Herbst RS</searchLink>; Yale Cancer Center, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Gettinger+SN%22">Gettinger SN</searchLink>; Yale Cancer Center, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Moinpour+CM%22">Moinpour CM</searchLink>; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227503089%22">Journal of the National Cancer Institute</searchLink> [J Natl Cancer Inst] 2023 Apr 11; Vol. 115 (4), pp. 437-446.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7503089 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200278874%22">00278874 </searchLink><i>NLM ISO Abbreviation: </i>J Natl Cancer Inst <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36625510
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/jnci/djad003
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 437
    Titles:
      – TitleFull: Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Unger JM
      – PersonEntity:
          Name:
            NameFull: Qian L
      – PersonEntity:
          Name:
            NameFull: Redman MW
      – PersonEntity:
          Name:
            NameFull: Tavernier SS
      – PersonEntity:
          Name:
            NameFull: Minasian L
      – PersonEntity:
          Name:
            NameFull: Sigal EV
      – PersonEntity:
          Name:
            NameFull: Papadimitrakopoulou VA
      – PersonEntity:
          Name:
            NameFull: Leblanc M
      – PersonEntity:
          Name:
            NameFull: Cleeland CS
      – PersonEntity:
          Name:
            NameFull: Dzingle SA
      – PersonEntity:
          Name:
            NameFull: Summers TJ
      – PersonEntity:
          Name:
            NameFull: Chao H
      – PersonEntity:
          Name:
            NameFull: Madhusudhana S
      – PersonEntity:
          Name:
            NameFull: Villaruz L
      – PersonEntity:
          Name:
            NameFull: Crawford J
      – PersonEntity:
          Name:
            NameFull: Gray JE
      – PersonEntity:
          Name:
            NameFull: Kelly KL
      – PersonEntity:
          Name:
            NameFull: Gandara DR
      – PersonEntity:
          Name:
            NameFull: Bazhenova L
      – PersonEntity:
          Name:
            NameFull: Herbst RS
      – PersonEntity:
          Name:
            NameFull: Gettinger SN
      – PersonEntity:
          Name:
            NameFull: Moinpour CM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 04
              Text: 2023 Apr 11
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1460-2105
          Numbering:
            – Type: volume
              Value: 115
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Journal of the National Cancer Institute
              Type: main
ResultId 1